Real-World Efficacy and Safety of Combination Nivolumab Plus Ipilimumab for Untreated, Unresectable, Pleural Mesothelioma: the Meso-Immune (gfpc 04-2021) Trial
LUNG CANCER(2024)
Key words
Pleural mesothelioma,Immunotherapy,Real -world data,Survival,Safety
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined